Recent Updates
Recently added Catalysts
RCEL Negative Sentiment Score: 30/100

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Key Takeaway: Bragar Eagel & Squire, P.C. has initiated an investigation into potential claims against AVITA Medical, Inc. following the company's disclosure of a significant backlog in unpaid provider claims related to its Recell product. This backlog, attributed to delays by Medicare & Medicaid Services in adjudicating claims, has reportedly led to reduced utilization of Recell and financial losses for its stockholders. The investigation may ascertain whether AVITA has violated any federal securities laws amid these developments.

Market Sentiment Analysis

CONCERNS & RISKS

  • The investigation indicates potential violations of federal securities laws by Avita Medical.
  • A significant backlog of unpaid claims for Recell procedures has created uncertainty among providers.
  • The company's share price declined by approximately 21% following negative financial results.

Full Press Release Details

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Avita (RCEL) To Contact Him Directly To Discuss Their Options
If you purchased or acquired stock in Avita and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Click here to participate in the action.
NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) --
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ:RCEL) on behalf of Avita stockholders. Our investigation concerns whether Avita has violated the federal securities laws and/or engaged in other unlawful business practices.
Investigation Details:
On August 7, 2025, Avita released its second quarter 2025 financial results, revealing “a six-month backlog in unpaid provider claims for Recell procedures impacted first-half demand.” The Company explained that contractors assigned by the Centers for Medicare & Medicaid Services to determine pricing of the Company’s wound care product, Recell, “neither assigned a price or assigned an inadequate price and failed to adjudicate claims in a timely manner.” As a result, “claims accumulated from January through June, creating a significant backlog of unpaid claims and inadequately paid claims to providers for Recell procedures. This lack of resolution created uncertainty among providers regarding payment expectations and timelines, which led to a reduction in Recell utilization during the first half of the year.”
On this news, the price of AVITA’s shares declined by $1.13 per share, or approximately 21%, from $5.38 per share on August 7, 2025 to close at $4.25 on August 8, 2025.
If you purchased or otherwise acquired Avita shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

Bragar Eagel & Squire

Frequently Asked Questions

How can investors affected by Avita losses get help?

Investors can contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire.

What triggered the investigation into Avita Medical?

Avita's backlog of unpaid provider claims impacted its financial results and stock.

What significant event occurred on August 7, 2025?

Avita reported a backlog in unpaid claims, leading to a drop in share price.

Is there a cost for investors to seek legal advice?

There is no cost or obligation for investors to discuss their options.

Where is Bragar Eagel & Squire located?

The firm has offices in New York, South Carolina, and California.

Last updated: Oct 16, 2025